ORBIMED ADVISORS LLC - 31 Dec 2024 SCHEDULE 13G Report for ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED CAPITAL LLC
Security: ADC Therapeutics SA Common Shares, par value CHF 0.08 per share
Symbol: ADCT
Shares outstanding: 95,494,806 shares
Disclosed Ownership: 3,437,813 shares
Ownership: 3.6%
Form type: SCHEDULE 13G
Filing time: 14 Feb 2025, 16:35:24 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	2.6%	2,530,638	0	2,530,638	/s/ Carl L. Gordon	Carl L. Gordon/Member
ORBIMED CAPITAL LLC	3.6%	3,437,813	3,437,813	0	/s/ Carl L. Gordon	Carl L. Gordon/Member